Aims and Scope
Diabetes Therapy is an open access, peer-reviewed, rapid-publication journal focused on cutting-edge research in the prevention, treatment, management, and education of diabetes and related disorders including obesity and metabolic syndromes.
Emphasis is placed on the publication of high-quality original research and review articles covering preclinical, clinical (phase 1-4), and postmarketing studies on new and existing therapies and devices. Pharmacoeconomic, epidemiological, outcomes, and quality of life studies are also encouraged, along with research relating to patient management and education.
The journal aims to promote better management and care of patients with diabetes and provides expert opinion on current advances in the field through editorials.
With every article freely available through open access your message has maximum dissemination to a worldwide audience of academics, physicians, and specialists including diabetologists, cardiologists, endocrinologists, health care providers, diabetes educators, psychologists, and the public. All articles are available to be read, downloaded and reproduced (with the appropriate level of author acknowledgment).
Every article:
- Open access: Article is freely available to everyone.
- Rapid publication: Peer review decision within 2 weeks. Online publication 3-4 weeks after acceptance.
- Bulleted summary slide: Freely accessible single slide sits with the article online. Gets key points across to physicians quickly and encourages readership from a broader audience.
- Broad aims and scope: Original research and reviews considered whateverthe size or outcome.
- Commercial understanding: Compliance with Good Publication Practice.
Other optional features to enhance your article:
- Article slide deck - 4-6 slides, allowing a more extensive summary of keypoints (with illustrations where appropriate). In a transferable format for use in presentations.
- Videos and animated summaries - Advanced article functionality to improve speed and level of understanding. Convertible into an app for demo to patients.
- Interactive case study - Expert knowledge from Editor-in-Chief ensures challenging multiple choice options for diagnosis and treatment.
Please contact alison.brown@springer.com for more information on these features.